Holiday Season’s Greetings and New Year’s message from CEO of Accelsiors
Dear Colleagues, Clients, Partners, Friends,
As 2017 nears conclusion at Accelsiors, we proudly look back on our accomplishments. It has been a pleasure to work with all of our clinical research partners this year. Thank you to all our friends, partners, research staff and vendors for placing your confidence in Accelsiors CRO.
Some of our key company highlights in 2017:
Celebrated our 15th anniversary being globally active in the clinical research arena as a full-service CRO.
Expanded our operations to Asian market by opening a new office in Gurgaon, India under the leadership of Dr. Shabbir Rangwala, VP of Operations, Asia.
Expanded our team which now counts over 220 permanent employees along with addition of network of nearly 80 highly specialized consultants.
Lead the 2nd Annual Biosimilars Forum that attracted several of the world leaders in Biosimilar and Nanosimilar / Nanomedicines clinical research.
Introduced new, proprietary, data-driven method called ACCELEROUTE™ for ensuring timely and cost-effective recruitment and study conduct.
Started supporting new Phase 1 to Phase 3 projects in endocrinology, hepatology, nephrology, central nervous system, biosimilars, pulmonology and orphan diseases.
As the New Year unwinds,the professional team of Accelsiors is ready to tackle any challenge and accelerate your development program by our:
Newly improved ACCELEROUTE™ methodology which provides an accelerated and more predictable solution for your development program from the Quickest Patient Access solutions to delivery of Reliable Results with on-time, on-cost project fulfillment.
Strengthened international presence to manage global trials of high complexity.
Comprehensive and tailored services to support you from transitioning from preclinical development to Phase 1 and through every stage of your clinical development.
We look forward to working together in 2018 and beyond by creating and executing your drug development plans and continuing to support your development pipeline.
On behalf of the Accelsiors management and staff, I would like to wish all our collaborators a wonderful holiday season and a rewarding New Year.
Mihály Juhász, MD